APLNR and liver cancer: The model genes were mainly enriched in the apelin‐HDAC5‐KLF2 angiogenesis axis and mediated the occurrence of the PI3K‐AKT signalling pathway as well as the MAPK signalling pathway, providing direction for targeting the apelin/APJ pathway in liver cancer (Figure S6).